Tau Homeostasis Via Proteasomal and Autophagic Activity

Principal Investigator

Centre for Addiction and Mental Health (CAMH)
Toronto, Ontario
This grant is made possible by a generous bequest from the Estate of Donald A. Reitzer.

Project Goals

Dr. Wai Haung Yu and colleagues will determine how the natural protein recycling systems, called the ubiquitin-proteasome (UPS) and autophagic-lysosome system (A-LS), act in concert to maintain healthy levels and quality of proteins. In Alzheimer's disease (AD), protein clumping is a hallmark that is often accompanied by failure of UPS and A-LS, suggesting that these two recycling pathways are important for disease prevention. Along with improving the understanding of these two mechanisms, these researchers will test drug candidates for enhancement of UPS and A-LS function in reducing tau clumping and for restoring long-lived UPS and A-LS protein recycling activity.

Project Summary

Dr. Wai Haung Yu and colleagues are exploring how proteins—the building blocks of all cells—are recycled in brain cells, and what happens when there is a malfunction in the machinery to break down and recycle redundant and toxic proteins.  One of the main hallmarks of Alzheimer's disease is the presence of aggregated protein deposits, including one set of deposits caused by a protein called tau. This can be a result of proteins that are not degraded by systems called ubiquitin-proteasome (UPS) or autophagic-lysosomal (A-LS), which are two of the primary ways cells get rid of and recycle their junk. The UPS and A-LS pathways are important for maintaining quality control in a cell, and when they fail, the cell begins to accumulate junk proteins, which can be harmful to the cell and can negatively affect its operations and/or lead to disease. Although these two pathways are vital to survival, the connection between them is not well understood in diseases like AD. Moreover, this work will also determine whether scientists can protect and reverse the disease process by improving UPS and A-LS function to reduce the buildup of proteins like tau and preserve healthy brain cell function.

First published on: July 10, 2012

Last modified on: June 18, 2024